Conditions: Kidney Transplant
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 16
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate how well adolescent kidney transplant patients tolerate a single dose of belatacept they receive at least 6 months after transplant surgery, and how their body handles the drug.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Belatacept
Intervention descriptions: intervention 1: Single intravenous infusion of belatacept, 7.5 mg/kg

Protocol document: